Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beardsley

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2016
Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in MiceRobert A Owens, Bogna Ignatowska-Jankowska, Mohammed Mustafa, et al.
Neuropharmacology|July 5, 2017
Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB<sub>1</sub> receptor-mediated discriminative stimulus in miceRobert A Owens, Mohammed A Mustafa, Bogna M Ignatowska-Jankowska, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Detection and characterisation of neurotransmitters, particularly peptides, in the gastrointestinal tractJ B Furness, M Costa, R Murphy, et al.
Neuroscience Letters|January 25, 2017
Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1bRachel M Enga, Ann C Rice, Pamela Weller, et al.
European Journal of Pharmacology|November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorderYi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
JAMA Ophthalmology|March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaineAlan P Kozikowski, Kenneth M Johnson, Olivier Deschaux, et al.
Ophthalmology|June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Cell Communication and Signaling : CCS|June 20, 2020
Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cellsSarah B Gitto, Jordan M Beardsley, Sai Preethi Nakkina, et al.
Ophthalmology and Therapy|August 4, 2016
Strategies for Improving Patient Comfort During Intravitreal Injections: Results from a Survey-Based StudyJessica Gomez, Dara D Koozekanani, Alex Z Feng, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2016
Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in MiceRobert A Owens, Bogna Ignatowska-Jankowska, Mohammed Mustafa, et al.
Neuropharmacology|July 5, 2017
Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB<sub>1</sub> receptor-mediated discriminative stimulus in miceRobert A Owens, Mohammed A Mustafa, Bogna M Ignatowska-Jankowska, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Detection and characterisation of neurotransmitters, particularly peptides, in the gastrointestinal tractJ B Furness, M Costa, R Murphy, et al.
Neuroscience Letters|January 25, 2017
Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1bRachel M Enga, Ann C Rice, Pamela Weller, et al.
European Journal of Pharmacology|November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorderYi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
JAMA Ophthalmology|March 22, 2014
Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaineAlan P Kozikowski, Kenneth M Johnson, Olivier Deschaux, et al.
Ophthalmology|June 24, 2014
Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trialEric B Suhler, Lyndell L Lim, Robert M Beardsley, et al.
Cell Communication and Signaling : CCS|June 20, 2020
Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cellsSarah B Gitto, Jordan M Beardsley, Sai Preethi Nakkina, et al.
Ophthalmology and Therapy|August 4, 2016
Strategies for Improving Patient Comfort During Intravitreal Injections: Results from a Survey-Based StudyJessica Gomez, Dara D Koozekanani, Alex Z Feng, et al.
Pageof 22